title: The bone substudy of MA.27: does bone make a difference?
authors.affiliation: Division of Hematology and Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15232, USA.
authors.forename: Aju
authors.initials: A
authors.lastname: Mathew
authors.affiliation: Division of Hematology and Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15232, USA. Electronic address: brufskyam@upmc.edu.
authors.forename: Adam
authors.initials: A
authors.lastname: Brufsky
mesh_terms: D000077384:Anastrozole; D000730:Androstadienes / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D009570:Nitriles / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D000730:Androstadienes; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole; C056516:exemestane